Incidence, Prevalence, and Mortality of Psychosis Associated with Parkinson's Disease (1991-2010)

被引:11
|
作者
Stang, Cole D. [1 ]
Mullan, Aidan F. [2 ]
Camerucci, Emanuele [1 ]
Hajeb, Mania [1 ]
Turcano, Pierpaolo [3 ]
Martin, Peter [2 ]
Mielke, Michelle M. [2 ]
Josephs, Keith A. [1 ]
Splett, Matthew [4 ]
Abler, Victor [4 ]
Boeve, Bradley F. [1 ]
Bower, James H. [1 ]
Savica, Rodolfo [1 ,2 ]
机构
[1] Mayo Clin, Dept Neurol, 200 First St,SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[3] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA
[4] ACADIA Pharmaceut Inc, San Diego, CA USA
关键词
Parkinsonism; psychosis; hallucinations; delirium; antipsychotics; DRUG-INDUCED PSYCHOSIS; RECORDS-LINKAGE SYSTEM; DATA RESOURCE PROFILE; OLMSTED COUNTY; HALLUCINATIONS; POPULATION; CLOZAPINE; QUETIAPINE; SYMPTOMS; DEMENTIA;
D O I
10.3233/JPD-213035
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BACKGROUND: Parkinson's disease (PD)-associated psychosis is a well-known non-motor complication, occurring years after diagnosis of PD. Incidence data vary across different studies highlighting a need for long-term observation and clinical definition. OBJECTIVE: To determine the incidence of psychosis in patients with PD and to investigate their survival in an incident cohort study from 1991-2010 in Olmsted County, MN. METHODS: We used the Rochester Epidemiology Project to define an incident-cohort study of parkinsonism (1991-2010) in Olmsted County, MN. A movement-disorder specialist reviewed the electronic medical records and applied diagnosis criteria to PD. Psychosis was diagnosed using of NINDS/NIMH unified criteria. RESULTS: We identified 669 cases of parkinsonism; 297 patients were clinically diagnosed with PD. 114/297 (38.4%) patients had evidence of psychosis (60% male); the median onset age of psychosis was 79.4 years. The incidence of Parkinson's disease psychosis (PDP) was 4.28/100 person-years. PDP patients had a 71% increased risk of death compared to PD patients. In PD patients without psychosis, men had 73.4% increased risk of death compared to women, whereas no significant sex difference was observed among PDP men vs. women. Of 114 patients diagnosed with psychosis, 59 were treated with antipsychotics. There was no significant difference in survival between treated and untreated patients. CONCLUSION: PDP increased the odds of death compared to PD patients. Men with PD without psychosis had greater odds of death compared to women; however, in PD with psychosis the odds of death were comparable among sexes. Lastly, treatment with anti-psychotics did not significantly affect survival.
引用
收藏
页码:1319 / 1327
页数:9
相关论文
共 50 条
  • [41] Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis
    Wilby, Kyle John
    Johnson, Eric G.
    Johnson, Hannah E.
    Ensom, Mary H. H.
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (08) : 682 - 695
  • [42] Why psychosis is frequently associated with Parkinson's disease?
    Zhong, Jingmei
    Wu, Shaoyuan
    Zhao, Ying
    Chen, Hui
    Zhao, Naiwei
    Zheng, Kunwen
    Zhao, Zhong
    Chen, Wenli
    Wang, Bo
    Wu, Kunhua
    NEURAL REGENERATION RESEARCH, 2013, 8 (27) : 2548 - 2556
  • [43] Evidence for the use of pimavanserin in the treatment of Parkinson's disease psychosis
    Sarva, Harini
    Henchcliffe, Claire
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2016, 9 (06) : 462 - 473
  • [44] The Emerging Role of Pimavanserin in the Management of Parkinson's Disease Psychosis
    Hermanowicz, Neal
    Alva, Gustavo
    Pagan, Fernando
    Espay, Alberto J.
    Patel, Amita
    Madrid, Katya Cruz
    Kremens, Daniel
    Kenney, Jim
    Arquette, Sheila
    Tereso, Gary
    Lopes, Maria
    Farnum, Carolyn
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (06) : S2 - S8
  • [45] Emerging role of psychosis in Parkinson's disease: From clinical relevance to molecular mechanisms
    Zhang, Shuo
    Ma, Yan
    WORLD JOURNAL OF PSYCHIATRY, 2022, 12 (09): : 1127 - 1140
  • [46] Clinicopathologic Discrepancies in a Population-Based Incidence Study of Parkinsonism in Olmsted County: 1991-2010
    Turcano, Pierpaolo
    Mielke, Michelle M.
    Josephs, Keith A.
    Bower, James H.
    Parisi, Joseph E.
    Boeve, Bradley F.
    Savica, Rodolfo
    MOVEMENT DISORDERS, 2017, 32 (10) : 1439 - 1446
  • [47] Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists
    Martinez-Ramirez, Daniel
    Okun, Michael S.
    Jaffee, Michael S.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2016, 6 (04) : 319 - 330
  • [48] Psychosis in Parkinson's disease
    Marsh L.
    Current Treatment Options in Neurology, 2004, 6 (3) : 181 - 189
  • [49] Hallucinations and the spectrum of psychosis in Parkinson's disease
    Frei, Karen
    Truong, Daniel D.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 374 : 56 - 62
  • [50] Pimavanserin for the treatment of Parkinson's disease psychosis
    Friedman, Joseph H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (14) : 1969 - 1975